Cite
HARVARD Citation
Upadhyaya, P. et al. (n.d.). 706 BT7480, a fully synthetic tumor-targeted immune cell agonist (TICA™) induces tumor localized CD137 agonism and modulation of tumor immune microenvironment. Journal for immunotherapy of cancer. p. A424. [Online].